EGFR-Mutated Metastatic NSCLC: Evolving Practice Standards and Opportunities for Improving Outcomes

Download All

Gain global insights on the optimal care of patients with advanced EGFR-mutated NSCLC in this comprehensive online program including a Podcast and an on-demand Webcast of a CCO live Webinar, both featuring medical oncologists from the United States and Europe, along with expert-authored commentaries and a regularly updated downloadable slideset.

Enriqueta Felip, MD
Matthew Gubens, MD, MS
David Planchard, MD, PhD
Christian Rolfo, MD, PhD, MBA, Dr.hc.

ClinicalThought

Get up to date on current best practices in the treatment of metastatic NSCLC with actionable EGFR mutations, including expert advice on biomarker testing, therapy selection for newly diagnosed and progressive disease, and managing adverse events with EGFR inhibition.

Matthew Gubens, MD, MS Released: March 8, 2021

Thoracic oncologists Enriqueta Felip, MD, and Matthew Gubens, MD, MS, consider evolving practice standards for EGFR-mutated NSCLC in the EU and US.

Enriqueta Felip, MD Matthew Gubens, MD, MS Released: April 20, 2021

Get up to date on the current and future applications of liquid biopsy in the care of patients with EGFR mutation–positive advanced NSCLC.

Christian Rolfo, MD, PhD, MBA, Dr.hc. Released: June 1, 2021

In this expert commentary, gain insights into barriers to osimertinib access worldwide along with future directions in the management of patients with advanced EGFR-mutant NSCLC.

David Planchard, MD, PhD Released: July 29, 2021
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings